Eagle Pharmaceuticals Inc Says on May 28, Co Requested Hearing Before Hearings Panel of Nasdaq, Following Delisting Notice From Nasdaq - SEC Filing
Eagle Pharmicals Inc表示,在納斯達克向美國證券交易委員會提交退市通知後,該公司於5月28日要求在納斯達克聽證會小組舉行聽證會
Eagle Pharmaceuticals Inc Says on May 28, Co Requested Hearing Before Hearings Panel of Nasdaq, Following Delisting Notice From Nasdaq - SEC Filing
Eagle Pharmicals Inc表示,在納斯達克向美國證券交易委員會提交退市通知後,該公司於5月28日要求在納斯達克聽證會小組舉行聽證會
譯文內容由第三人軟體翻譯。